Clinical Trials
11 trialsNCT03206060 2026-04-24
Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paraganglioma
National Institutes of Health Clinical Center (CC)
Phase 2 Recruiting
NCT03604198 2026-04-21
Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing Syndrome
Corcept Therapeutics
Phase 2 Active not recruiting
NCT07470580 2026-03-13
ADERADHTA2
University Hospital, Toulouse
Phase NA Not yet recruiting
NCT01022515 2026-02-06
PHEO
University Hospital, Rouen
Phase NA Completed
NCT04530916 2025-11-17
WB2020
Colorado State University
Phase 1/2 Active not recruiting
NCT03697109 2025-07-16
GRACE
Corcept Therapeutics
Phase 3 Completed
NCT04373265 2024-02-23
Study of Relacorilant in Combination With Pembrolizumab for Patients With Adrenocortical Carcinoma Which Produces Too Much Stress Hormone (Cortisol)
Corcept Therapeutics
Phase 1 Completed
NCT05839483 2023-07-17
CXCR4 Targeted PET Imaging in APA Preoperative Localization Diagnosis
Zhongnan Hospital
Phase NA Unknown
NCT02804750 2019-10-15
Study to Evaluate CORT125134 in Participants With Cushing's Syndrome
Corcept Therapeutics
Phase 2 Completed
NCT02001051 2018-06-14
Study of Adrenalectomy Versus Observation for Subclinical Hypercortisolism
National Institutes of Health Clinical Center (CC)
Phase 2 Terminated
NCT01092078 2015-04-22
MISTER-B
NYU Langone Health
Phase NA Completed